RXBAR® and Orgain® Founders Partner with Award-Winning Consumer Products Lawyer, launching Firm with Roster of Legacy CPG Investors
With both passion and the experience of knowing what works, CPG veterans Andrew Abraham, CEO & Founder of Orgain®, Nick Giannuzzi, Founder & Partner of Giannuzzi Lewendon, and Peter Rahal, Founder of RXBAR®, have partnered to launch a growth equity investment firm focused on innovative consumer brands.
“We’re honored to officially launch Humble Growth and work closely with founders to propel their brands to new heights,” says co-founder Abraham. “We’ve built, scaled and exited our own brands and understand the ongoing challenges founders face when growing their brands firsthand.”
Now committed to consumer brands that help people lead healthier lives, the New York-based firm has $312 million committed to date with an impressive roster of investors coming from highly notable industry players that includes:
- Nestlé Health Science,
- Verlinvest, the evergreen consumer investors who have backed Oatly, Vita Coco and Chewy.com,
- Mike Repole, co-Founder of BODYARMOR and Super Drink,
- Gary Hirshberg, Founder & CEO of Stonyfield Farm,
- Paulo Lima (Co-Founder of IT Cosmetics, and
- and Sean Lang (Founder of Ainsworth Pet Nutrition.
The two highly successful consumer product entrepreneurs join with an industry lawyer who has over 25 years as a legal expert in the CPG sector to form Humble Growth’s strategy. Their goal is to change the conventional private equity model through their distinct involvement in their portfolio companies.
Investor Gary Hirshberg, co-Founder & Chief Organic Optimist of Stonyfield Farm, expresses his enthusiasm for what the Humble Growth founding team has accomplished and its potential for success.
“When the idea of Humble Growth began gaining momentum, I was thrilled to jump in as a founding investor…I would have killed to have had a Humble Growth available to support Stonyfield and help bring not only critical funding but also seasoned guidance during our growth years.”
